Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata
- 8 December 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 56 (7) , 903-906
Abstract
We studied the ability of five echinocandin-susceptible C. glabrata isolates to acquire in vitro resistance to anidulafungin and micafungin. All isolates became phenotypically resistant after 2–4 days of exposure to low and constant micafungin concentrations (P < .05). Mutations in the HS1 region of the FKS2 gene were found in all isolates. The acquisition of resistance was not related to the previous use of antifungal treatment in the patients or the presence of mutations at MSH2 gene. We found differences (P < .0001) in the median survival of Galleria mellonella larvae infected with FKS2 mutant isolates (5 days) and wild-type isolates (3 days).Keywords
Funding Information
- Instituto de Salud Carlos III (920200)
- Spanish Network for Research in Infectious Diseases (RD12/0015)
This publication has 18 references indexed in Scilit:
- In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata IsolatesAntimicrobial Agents and Chemotherapy, 2017
- Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of ResistanceFrontiers in Microbiology, 2016
- Echinocandin resistanceCurrent Opinion in Infectious Diseases, 2014
- Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin ResistanceAntimicrobial Agents and Chemotherapy, 2014
- Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011Antimicrobial Agents and Chemotherapy, 2014
- Antifungal resistance does not necessarily affectCandida glabratafitnessJournal of Chemotherapy, 2013
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory ConcentrationsClinical Infectious Diseases, 2013
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)Clinical Microbiology and Infection, 2012
- Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance MutationsAntimicrobial Agents and Chemotherapy, 2012
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata InfectionAntimicrobial Agents and Chemotherapy, 2008